Pershing Square, Pharma Join To Buy Botox Maker

Apr 22 2014 | 2:03pm ET

For its latest activist effort, Pershing Square Capital Management has already enlisted a buyer.

The New York-based hedge fund and Valeant Pharmaceuticals have joined forces in a hostile bid for Allergan Inc., the pharmaceutical company that makes Botox. Since striking its agreement with Valeant, Pershing Square has bought up some 9.7% of Allergan’s shares.

The deal, for cash and Valeant stock, is worth in excess of $45 billion.

Valeant has been seeking a deal for Allergan for a year, to no avail. The company said the merger would “create an unrivaled platform for growth and value creation in healthcare.”


In Depth

Debunking Conventional Investment Wisdom

Feb 8 2017 | 3:22pm ET

Due diligence in the hedge fund world has long involved some combination of the...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Future of Private Equity: New Opportunities, New Challenges

Feb 3 2017 | 6:41pm ET

The private equity industry’s astonishing rebound since the financial crisis has...

 

From the current issue of